These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 31790940)

  • 1. Influence of new versus traditional antiepileptic drugs on course and outcome of status epilepticus.
    Reindl C; Sprügel MI; Sembill JA; Mueller TM; Hagen M; Gerner ST; Kuramatsu JB; Hamer HM; Huttner HB; Madžar D
    Seizure; 2020 Jan; 74():20-25. PubMed ID: 31790940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.
    Beuchat I; Novy J; Rossetti AO
    CNS Drugs; 2017 Apr; 31(4):327-334. PubMed ID: 28337727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
    Hubert K; Knake S; Bauer S; Voss M; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2020 Aug; 109():107139. PubMed ID: 32417381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis.
    Jaques L; Rossetti AO
    Epilepsy Behav; 2012 May; 24(1):70-3. PubMed ID: 22481040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of newer antiepileptic drugs and prognosis in adults with status epilepticus: Comparison between 2009 and 2017.
    Fatuzzo D; Novy J; Rossetti AO
    Epilepsia; 2018 Jul; 59(7):e98-e102. PubMed ID: 29851060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores.
    Giovannini G; Monti G; Tondelli M; Marudi A; Valzania F; Leitinger M; Trinka E; Meletti S
    Seizure; 2017 Mar; 46():31-37. PubMed ID: 28226274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the value of topiramate in refractory status epilepticus.
    Madžar D; Kuramatsu JB; Gerner ST; Huttner HB
    Seizure; 2016 May; 38():7-10. PubMed ID: 27039016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one-year prospective study of refractory status epilepticus in Modena, Italy.
    Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
    Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
    Hottinger A; Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.
    Bachhuber A; Lasrich M; Halmer R; Fassbender K; Walter S
    CNS Neurosci Ther; 2016 Mar; 22(3):178-83. PubMed ID: 26841716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
    Holtkamp M; Othman J; Buchheim K; Meierkord H
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Unease When Using Anesthetics for Treatment-Refractory Status Epilepticus: Still Far Too Many Questions.
    Opić P; Sutter R
    J Clin Neurophysiol; 2020 Sep; 37(5):399-405. PubMed ID: 32890061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory status epilepticus: a prospective observational study.
    Novy J; Logroscino G; Rossetti AO
    Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.